Nintedanib for progressive fibrosing interstitial lung disease: how many meet criteria in a UK district general hospital systemic sclerosis cohort?
Ho GN Douglas KMJ
Ho GN
Douglas KMJ
Abstract
MIDER Authors
Citations
Altmetric:
Date
03/04/2023
Type
Article
Subject
Rheumatology
Collections
Citation
Ho GN, Douglas KMJ. Nintedanib for progressive fibrosing interstitial lung disease: how many meet criteria in a UK district general hospital systemic sclerosis cohort? Rheumatol Adv Pract. 2023 Apr 3;7(2):rkad037. doi: 10.1093/rap/rkad037. PMID: 37065010; PMCID: PMC10097451.
Journal / Source Title
Rheumatology Advances in Practice
DOI
10.1093/rap/rkad037
PMID
37065010
Publisher
Oxford University Press